Webinar: Navigating complexity in CAR-T therapy delivery

ATMP Denmark invites you to an upcoming webinar on how hospitals can navigate the growing complexity of delivering CAR-T therapies – from certification requirements to clinical practice.

As CAR T-cell therapies continue to transform patient care, hospitals face increasing complexity in delivering these treatments safely, effectively, and in compliance with regulatory requirements.

Why it matters

CAR-T therapies are not administered like many conventional medicines such as small molecules and biological medicines. They involve a complex treatment pathway.

Before Danish hospitals can offer approved CAR-T therapies, they must meet extensive requirements for certification, training, documentation, and quality. While these measures are essential to ensure patient safety, quality, and traceability, they can also create significant administrative and practical challenges in clinical practice.

The challenge

Many CAR-T products follow similar clinical pathways, but certification, training, audits, electronic systems, and documentation requirements are often handled separately for each individual product. This can lead to overlapping processes across clinical teams, pharmacies, laboratories, and hospitals.

What we will discuss

In this webinar, we will take a closer look at how growing regulatory and product-specific requirements affect CAR-T programs in Denmark, as well as experiences from the rest of Europe.

Together with experts from clinical practice, we will discuss opportunities for greater coordination and more streamlined approaches that maintain the highest standards of patient safety, quality, and compliance while reducing unnecessary administrative burden.

The webinar is relevant for clinicians, industry, authorities, and other stakeholders working with CAR-T and advanced therapies.

Download the program here
Register here: Registration
Date and time: October 21, 2–4 PM